All Publications Citing Use of MCE Products

• Nat Immunol. 2023 Oct;24(10):1685-1697. Venetoclax, BCH purchased from MCE.

• Nat Immunol. 2023 Oct;24(10):1654-1670. MK-0429 purchased from MCE.

• Cell Metab. 2023 Sep 7;S1550-4131(23)00304-2. Rosiglitazone, 7α,25-Dihydroxycholesterol, Liothyronine, Protein A/G Magnetic Beads, FGL2 Protein, Mouse (HEK293, His-Avi, Flag) purchased from MCE.

• Nat Immunol. 2023 Nov;24(11):1839-1853. DB1976 dihydrochloride purchased from MCE.

• Cell Metab. 2023 Aug 9;S1550-4131(23)00270-X. Gly-β-MCA purchased from MCE.

• Mol Cancer. 2023 Jul 13;22(1):110. BAY1217389, IP-10/CRG-2/CXCL10 Protein, Mouse purchased from MCE.

• Cell Metab. 2023 Sep 5;35(9):1630-1645.e5. Pevonedistat purchased from MCE.

• Nat Immunol. 2023 Sep;24(9):1443-1457. Imatinib Mesylate purchased from MCE.

• Cell Metab. 2023 Jun 14;S1550-4131(23)00209-7. MG-132, LW6 purchased from MCE.

• Mol Cancer. 2023 May 20;22(1):86. Trametinib, BI 2536, Sotorasib, MG-132, Omipalisib, Fedratinib, IL-6 Protein, Rat (HEK293), MSP/MST1 Protein, Mouse (C677A, HEK293) purchased from MCE.

• Mol Cancer. 2023 May 9;22(1):81. Actinomycin D purchased from MCE.

• Mol Cancer. 2023 Apr 27;22(1):77. α-Amanitin purchased from MCE.

• Cell Metab. 2023 Apr 12;S1550-4131(23)00126-2. O-Propargyl-Puromycin purchased from MCE.

• Nat Immunol. 2023 May;24(5):767-779. GW627368, TG6-10-1 purchased from MCE.

• Mol Cancer. 2023 Mar 30;22(1):64. (+)-JQ-1, AZD-8835, Copanlisib purchased from MCE.

• Cell Metab. 2023 Apr 12;S1550-4131(23)00095-5. Cell Counting Kit-8 purchased from MCE.

• Nat Immunol. 2023 May;24(5):827-840. Pexidartinib purchased from MCE.

• Nat Immunol. 2023 May;24(5):802-813. LCL521 purchased from MCE.

• Nat Immunol. 2023 May;24(5):780-791. Nutlin-3a purchased from MCE.

• Nat Immunol. 2023 Mar;24(3):423-438. UK-5099 purchased from MCE.

• Cell Metab. 2023 Jan 3;35(1):200-211.e9. Oligomycin A, 3-Hydroxybutyric acid, Mitoquinone mesylate, AR-C155858, Troglitazone, Glutaminase C-IN-1, Telaglenastat, CCCP, SB 204990 purchased from MCE.

• Mol Cancer. 2023 Jan 24;22(1):17. SB 202190, ApoA-IV Protein, Human (HEK293, His) purchased from MCE.

• Nat Immunol. 2023 Jan;24(1):162-173. A-485, Trichostatin A, L-NMMA acetate, 3-TYP, Pyridoxal 5'-​phosphate monohydrate, HA/Hemagglutinin Protein, H11N2 (AAY85533, sf9, His) purchased from MCE.

• Nat Immunol. 2023 Mar;24(3):531-544. Bortezomib purchased from MCE.

• Cell Metab. 2023 Jan 3;35(1):101-117.e11. DCP-LA, Metformin hydrochloride purchased from MCE.

• Nat Immunol. 2022 Dec 21. L-Ascorbic acid, BMP signaling agonist sb4 purchased from MCE.

• Mol Cancer. 2022 Dec 13;21(1):217. Cell Counting Kit-8 purchased from MCE.

• Cell Metab. 2022 Nov 11;S1550-4131(22)00490-9. GW 441756, Oxidopamine hydrochloride, Lonidamine, VIP(6-28)(human, rat, porcine, bovine), 2-Deoxy-D-glucose, WZB117, Atropine, V-9302, Rimegepant, ESI-05, PACAP (1-27), human, ovine, rat, Capsaicin, Netupitant, Fasentin, GSK3179106, ANA-12, NGFR Protein, Human (HEK293), Activin RIB/ALK-4 Protein, Human (HEK293, His), Catalase Protein, Human purchased from MCE.

• Nat Immunol. 2022 Nov 28. PI4KIIIbeta-IN-9, PI4KIIIbeta-IN-10, MCC950, TRAIL R2/TNFRSF10B Protein, Human (HEK293), Collagen alpha-1(XVIII) chain/COL18A1 Protein, Mouse (HEK293, His) purchased from MCE.

• Cell Metab. 2022 Dec 6;34(12):2018-2035.e8. Chlorpromazine, EIPA, Amiloride purchased from MCE.

• Cell Metab. 2022 Nov 1;34(11):1843-1859.e11. ML133 hydrochloride, D-Luciferin, BPTES, 2-Deoxy-D-glucose, MeAIB, DiBAC4(3), UK-5099, Etomoxir sodium salt, BTN3A1/CD277 Protein, Human (HEK293, His) purchased from MCE.

• Cell Metab. 2022 Oct 4;34(10):1548-1560.e6. 25-Hydroxycholesterol, CD63 Protein, Rat (HEK293, His) purchased from MCE.

• Mol Cancer. 2022 Aug 30;21(1):171. Rapamycin, Palbociclib isethionate purchased from MCE.

• Cell Metab. 2022 Aug 19;S1550-4131(22)00345-X. Lonidamine purchased from MCE.

• Cell Metab. 2022 Aug 11;S1550-4131(22)00310-2. FCCP, Atglistatin, BANF1 Antibody (YA1740) purchased from MCE.

• Cell Metab. 2022 Aug 15;S1550-4131(22)00313-8. SB-431542 purchased from MCE.

• Nat Immunol. 2022 Aug 22. Protein A/G Magnetic Beads purchased from MCE.

• Nat Immunol. 2022 Aug;23(8):1193-1207. Selisistat, MG-132, ALDH1A3 Protein, Human (His) purchased from MCE.

• Nat Immunol. 2022 Jul;23(7):1021-1030. GSK2606414 purchased from MCE.

• Cell Metab. 2022 Aug 2;34(8):1151-1167.e7. GCN2iB purchased from MCE.

• Mol Cancer. 2022 Jun 23;21(1):135. ML228 purchased from MCE.

• Cell Metab. 2022 Jun 7;S1550-4131(22)00191-7. Protein A/G Magnetic Beads purchased from MCE.

• Mol Cancer. 2022 Apr 27;21(1):106. Pentoxifylline purchased from MCE.

• Mol Cancer. 2022 Mar 18;21(1):77. BAY 11-7082, XCT790, WH-4-023, Plicamycin, PCDH7 Protein, Human (sf9, His) purchased from MCE.

• Mol Cancer. 2022 May 10;21(1):112. 740 Y-P, LY294002 purchased from MCE.

• Cell Metab. 2022 Mar 8;S1550-4131(22)00054-7. GSK2656157 purchased from MCE.

• Cell Metab. 2022 Mar 10;S1550-4131(22)00083-3. AM966, Varespladib, Ki16425 purchased from MCE.

• Cell Metab. 2022 Feb 7;34(3):424-440.e7. (-)-Huperzine A, AZD-7762, Pantoprazole, Doxorubicin hydrochloride, Amsacrine, Xanthone, Diminazene aceturate, Methazolamide, Imatinib, Pyroxamide, A 779, Phensuximide, Tranilast, Anagrelide hydrochloride, Harpagoside, DX600, Ofloxacin, Entinostat, Clebopride malate, PDE1C Protein, Human (sf9, His-GST) purchased from MCE.

• Mol Cancer. 2022 Feb 4;21(1):35. Idelalisib, Ibrutinib purchased from MCE.

• Cell Metab. 2022 Feb 1;34(2):285-298.e7. Clozapine N-oxide purchased from MCE.